WHO ICTRP trial
Impact of macrolides antibiotics in mortality of patients infected by HIV with…
RBR-8wtq2b · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Not Recruiting
Key facts
| Trial ID | RBR-8wtq2b |
|---|---|
| Public title | Impact of macrolides antibiotics in mortality of patients infected by HIV with community-acquired pneumonia. |
| Scientific title | Impact of macrolides in mortality of patients infected by HIV with pneumonia: a randomized clinical trial |
| Primary sponsor | Instituto de Infectologia Emílio Ribas |
| Secondary sponsors | Fundação de Amparo à Pesquisa do Estado de São Paulo;Faculdade de Medicina da Universidade de São Paulo |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Not Recruiting |
| Study type | Intervention |
| Countries | Brazil |
| Conditions | Pneumonia, HIV.;B20-B24 |
| Interventions | 228 patients were assigned to receive one of two schemes, in 1:1 proportion: Scheme 1 (114 patients): monotherapy with ceftriaxone plus placebo for at least 7 days, ceftriaxone 1g IV 12/12h + SF0,9% 500mL IV 1x/day OR ceftriaxone 1g IV… |
| Registration date | Aug 28, 2015 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: